A phase II evaluation of menogaril in cisplatin-refractory advanced ovarian carcinoma. A collaborative trial of the North Central Cancer Treatment Group and the Mayo Clinic. (Record no. 1836443)

MARC details
000 -LEADER
fixed length control field 01597 a2200445 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250511205710.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 199108s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 0008-543X
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1002/1097-0142(19910815)68:4<730::aid-cncr2820680411>3.0.co;2-c
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Long, H J
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 19910828
245 00 - TITLE STATEMENT
Title A phase II evaluation of menogaril in cisplatin-refractory advanced ovarian carcinoma. A collaborative trial of the North Central Cancer Treatment Group and the Mayo Clinic.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. Cancer
Date of publication, distribution, etc. Aug 1991
300 ## - PHYSICAL DESCRIPTION
Extent 730-2 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Clinical Trial; Journal Article; Multicenter Study; Research Support, U.S. Gov't, P.H.S.
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Adult
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Aged
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antineoplastic Agents
General subdivision adverse effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Carcinoma
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Cisplatin
General subdivision therapeutic use
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Drug Evaluation
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Female
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Menogaril
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Middle Aged
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Nogalamycin
General subdivision adverse effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Ovarian Neoplasms
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Recurrence
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Remission Induction
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Survival Analysis
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Laurie, J A
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Wieand, H S
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Edmonson, J H
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Levitt, R
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Krook, J E
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Abu-Ghazaleh, S
773 0# - HOST ITEM ENTRY
Title Cancer
Related parts vol. 68
-- no. 4
-- p. 730-2
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1002/1097-0142(19910815)68:4<730::aid-cncr2820680411>3.0.co;2-c">https://doi.org/10.1002/1097-0142(19910815)68:4<730::aid-cncr2820680411>3.0.co;2-c</a>
Public note Available from publisher's website

No items available.